Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy E Davidson

Showing results (181-190 of 285) with videos related to

Pageof 29
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|January 9, 2016
Transforming Cancer Prevention through Precision Medicine and Immune-oncologyThomas W Kensler, Avrum Spira, Judy E Garber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2016
Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast CancerRekha Gyanchandani, Yan Lin, Hui-Min Lin, et al.
Breast Cancer Research and Treatment|August 19, 2015
Developing in vitro models of human ductal carcinoma in situ from primary tissue explantsDaniel D Brown, David J Dabbs, Adrian V Lee, et al.
Cancer|September 15, 2020
Impact of adjuvant trastuzumab on locoregional failure rates in a randomized clinical trial: North Central Cancer Treatment Group N9831 (alliance) studyCarlos E Vargas, Cameron S Thorpe, Amylou C Dueck, et al.
Hormones & Cancer|June 27, 2015
A Role for Histone H2B Variants in Endocrine-Resistant Breast CancerShweta R Nayak, Emily Harrington, David Boone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian SuppressionHarold J Burstein, Christina Lacchetti, Holly Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cellsYi Huang, Erin R Hager, Dawn L Phillips, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2018
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused UpdateHarold J Burstein, Christina Lacchetti, Holly Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancerBryan P Schneider, Fengmin Zhao, Molin Wang, et al.
Cancer|August 29, 2012
Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancerJoseph A Sparano, Molin Wang, Fengmin Zhao, et al.
Pageof 29

Showing results (181-190 of 285) with videos related to

Sort By:
Pageof 29
Cancer Prevention Research (Philadelphia, Pa.)|January 9, 2016
Transforming Cancer Prevention through Precision Medicine and Immune-oncologyThomas W Kensler, Avrum Spira, Judy E Garber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2016
Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast CancerRekha Gyanchandani, Yan Lin, Hui-Min Lin, et al.
Breast Cancer Research and Treatment|August 19, 2015
Developing in vitro models of human ductal carcinoma in situ from primary tissue explantsDaniel D Brown, David J Dabbs, Adrian V Lee, et al.
Cancer|September 15, 2020
Impact of adjuvant trastuzumab on locoregional failure rates in a randomized clinical trial: North Central Cancer Treatment Group N9831 (alliance) studyCarlos E Vargas, Cameron S Thorpe, Amylou C Dueck, et al.
Hormones & Cancer|June 27, 2015
A Role for Histone H2B Variants in Endocrine-Resistant Breast CancerShweta R Nayak, Emily Harrington, David Boone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian SuppressionHarold J Burstein, Christina Lacchetti, Holly Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cellsYi Huang, Erin R Hager, Dawn L Phillips, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2018
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused UpdateHarold J Burstein, Christina Lacchetti, Holly Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancerBryan P Schneider, Fengmin Zhao, Molin Wang, et al.
Cancer|August 29, 2012
Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancerJoseph A Sparano, Molin Wang, Fengmin Zhao, et al.
Pageof 29